Huntington National Bank Bio Techne Corp Transaction History

Huntington National Bank

$13.8 Billion
Q4 2024

A detailed history of Huntington National Bank transactions in Bio Techne Corp stock. As of the latest transaction made, Huntington National Bank holds 1,078 shares of TECH stock, worth $67,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,078

Previous 756 42.59%

Holding current value

$67,051

Previous $60,000 28.33%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$66.37 - $78.17 $21,371 - $25,170	322 Added 42.59%	1,078 $77,000
Q3 2024 Nov 06, 2024	BUY	$70.96 - $82.35 $14,901 - $17,293	210 Added 38.46%	756 $60,000
Q2 2024 Aug 08, 2024	BUY	$62.12 - $84.15 $7,019 - $9,508	113 Added 26.1%	546 $39,000
Q1 2024 May 03, 2024	BUY	$65.98 - $77.09 $12,866 - $15,032	195 Added 81.93%	433 $30,000
Q4 2023 Feb 07, 2024	BUY	$52.83 - $78.22 $1,215 - $1,799	23 Added 10.7%	238 $18,000
Q3 2023 Nov 08, 2023	SELL	$67.52 - $89.42 $8,237 - $10,909	-122 Reduced 36.2%	215 $14,000
Q2 2023 Aug 11, 2023	BUY	$73.76 - $85.98 $13,793 - $16,078	187 Added 124.67%	337 $27,000
Q1 2023 May 10, 2023	BUY	$71.62 - $86.62 $2,076 - $2,511	29 Added 23.97%	150 $11,000
Q4 2022 Feb 09, 2023	BUY	$80.67 - $352.29 $6,937 - $30,296	86 Added 245.71%	121 $10,000
Q3 2022 Nov 07, 2022	SELL	$282.54 - $391.85 $8,193 - $11,363	-29 Reduced 45.31%	35 $10,000
Q2 2022 Aug 09, 2022	BUY	$322.67 - $449.65 $3,872 - $5,395	12 Added 23.08%	64 $22,000
Q1 2022 May 10, 2022	SELL	$353.85 - $487.79 $17,692 - $24,389	-50 Reduced 49.02%	52 $23,000
Q3 2021 Oct 28, 2021	SELL	$444.87 - $538.88 $444 - $538	-1 Reduced 0.97%	102 $49,000
Q2 2021 Jul 30, 2021	SELL	$387.35 - $450.26 $15,881 - $18,460	-41 Reduced 28.47%	103 $46,000
Q1 2021 Apr 12, 2021	SELL	$314.62 - $411.0 $5,977 - $7,809	-19 Reduced 11.66%	144 $55,000
Q3 2020 Oct 30, 2020	BUY	$232.22 - $282.96 $1,161 - $1,414	5 Added 3.16%	163 $40,000
Q2 2020 Jul 30, 2020	SELL	$185.43 - $279.56 $36,158 - $54,514	-195 Reduced 55.24%	158 $42,000
Q1 2020 Apr 27, 2020	SELL	$161.17 - $221.51 $3,545 - $4,873	-22 Reduced 5.87%	353 $67,000
Q4 2019 Jan 17, 2020	BUY	$189.68 - $222.09 $36,987 - $43,307	195 Added 108.33%	375 $82,000
Q4 2018 Jan 28, 2019	SELL	$132.75 - $203.8 $92,925 - $142,660	-700 Reduced 79.55%	180 $26,000
Q3 2018 Oct 18, 2018	SELL	$147.44 - $204.11 $25,949 - $35,923	-176 Reduced 16.67%	880 $180,000
Q2 2018 Jul 19, 2018	SELL	$144.9 - $165.58 $120,411 - $137,596	-831 Reduced 44.04%	1,056 $156,000
Q1 2018 Apr 30, 2018	SELL	$131.46 - $151.04 $4,206 - $4,833	-32 Reduced 1.67%	1,887 $285,000
Q4 2017 Feb 02, 2018	SELL	$121.17 - $134.75 $13,328 - $14,822	-110 Reduced 5.42%	1,919 $249,000
Q3 2017 Oct 24, 2017	BUY	$113.59 - $123.78 $230,474 - $251,149	2,029	2,029 $245,000

Others Institutions Holding TECH

# of Institutions

617

Shares Held

156M

Call Options Held

161K

Put Options Held

12.7K

View Full List

About BIO-TECHNE Corp

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.44B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

More about TECH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Huntington National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Huntington National Bank with notifications on news.

Account

Huntington National Bank Bio Techne Corp Transaction History